Sitemap
Update: July 26th, 2009
Sitemap of posts on Orshe.com
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64
Posts
- Category: Wall Street Journal (continued)
- Could the Pill Make You Less Attractive?
- Could ‘Too Much Transparency’ Lead to Higher Health Prices?
- Countdown to Generic Lipitor: More Answers to Your Questions
- Countdown to Generic Lipitor: What Are Your Questions?
- Countdown to Generic Lipitor: What’s In It for Drugstores?
- Couples Therapy for One
- Court Ruling Means Federal Funding of Embryonic Stem Cell Research Can (Temporarily) Proceed
- Court: Former Pharma Exec Must Forfeit Millions in Salary, Bonus
- Court: State Budget Crisis Doesn’t Justify Pay Cut for Doctors
- Creams That Promise Beautiful Eyelashes
- Creating Fat Cells That Could (Someday) Drive Weight Loss
- Crowded Gyms Cause Fitness Fits
- Crowds Flock to Historic Supreme Court Hearing
- Crucial Power Dynamic of Washington
- CSPI’s ‘Xtreme Eating Awards’ May Disgust You — Or Make You Hungry
- CT Scans and Cancer: How to Minimize Your Risk
- Cuban Doctors Come In From the Cold
- Curing Behavior Issues in Kids
- Curing Behavioral Issues in Kids
- Curing Hepatitis C Will Take More Than New Treatments
- Cuts Are Coming for Glaxo R&D
- Cutting Cancer Risk in Dogs
- Cutting Costs with Better Care for Advanced Illness
- Cutting the Risk from CT Scans
- Cutting Wait Times in the Emergency Room
- Cutting-Edge Medical Care to Save Pets
- CVS Caremark: Testing Nudges to Improve Medication Compliance
- CVS Will Pay $75 Million After ‘Smurfers’ Bought Meth Ingredients
- CVS’s PBM-Pharmacy Combo Again Raises Conflict Concerns
- Cyclodextrin and Lorenzo’s Oil
- D.C. Power Players Exert Influence, In Absentia
- Damage Control: Dangers of da Vinci Surgery Robot
- Danger in the Deli? Listeria Risks Go Beyond Cantaloupe
- Dartmouth Atlas Project: Access to Primary Care No Guarantee of Better Care
- Daschle Puts Odds of Health Reform in 2009 at 50-50
- Daylight Savings Health Risks
- Deadly Chemical Plant Blast in Kentucky
- Deals from Pfizer, Novartis and AstraZeneca. Also: Snake Oil.
- Deals Near for UN Agencies to Buy Vaccine for H1N1 Flu
- Death Toll From ‘Average’ Flu Season Not So Easy to Come Up With
- Debate on Public-Health Option Turns to Talk of Co-Op
- Debate Over Drug Prices in India
- Decorated Cribs a No-No
- Defensive Medicine Not Just an Issue for Specialists, Survey Finds
- Defining a Nervous Breakdown
- Defining Adultery in the Age of Alzheimer's
- Defining the Loaded Phrase ‘Socialized Medicine’
- DeLauro and Waxman, Leaving No Shell Unturned, Ask for Egg Recall Info
- Delaying Generic Drugs Costs Patients & Taxpayers, EU Says
- Delays are Frequent When Surrogates Make DNR Decisions
- Democrats a Few Votes Short for Health Bill
- Democrats Squabble Over Health-Care Reform
- Democrats to Ditch Bipartisan Health Overhaul?
- Democrats' Uphill Battle to Mid-term Elections
- Dems May Seek Billions More From Drug and Device Companies
- Dems Scrambling on Eve of Health Vote
- Dems Want Obama's Guidance on Health Bill
- Dems’ $80 Billion Deal With Drug Industry Survives Senate Vote
- Dendreon Insiders Celebrate Provenge Approval With Stock Sales
- Dendreon Posts 4th-Quarter Profit on Royalty Stream Sale, Provenge
- Dendreon Shares Plummet as Company Withdraws Provenge Sales Forecast
- Dendreon Shares Rise on Medicare Report on Provenge
- Dendreon Shares Up on Provenge Medicare Coverage Meeting Scheduling
- Dendreon Starts Its Engines; No Green Light Yet from FDA
- Dendreon Submits Prostate Cancer Treatment to FDA. Again.
- Dental Care for Cats and Dogs
- Dentist Gives Glue Patient Reason to Smile
- Dentists Woo Runaway Patients With Foot Massage
- Desk-Bound Workers Now Standing to Attention
- Device Maker Bets $525 Million on Recycling Medical Devices
- Devices and Drugs in Focus at Big Cardiologists Meeting
- Diabetes Drugs: Here Come the GLiPs
- Diabetes Group Urges Surgery as Treatment Option
- Diabetes Roundup: Drugs, Stents and Stocks
- Diabetes Trend Points Up, Up, Up, CDC Stats Say
2009 -